Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,585 | 227 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $725.38 | 62 | $0 (2024) |
| Lilly USA, LLC | $372.61 | 20 | $0 (2024) |
| Novo Nordisk Inc | $323.98 | 20 | $0 (2024) |
| PFIZER INC. | $166.54 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $163.44 | 7 | $0 (2024) |
| Amgen Inc. | $151.17 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $150.64 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $125.54 | 8 | $0 (2024) |
| Mylan Specialty L.P. | $110.76 | 7 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $103.54 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,217 | 70 | Lilly USA, LLC ($168.83) |
| 2023 | $937.66 | 59 | ABBVIE INC. ($150.97) |
| 2022 | $848.55 | 57 | ABBVIE INC. ($183.10) |
| 2021 | $581.29 | 41 | AbbVie Inc. ($240.49) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Bone Health | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Inflammation | ||||||
| 09/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Obesity | ||||||
| 08/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Rare Disease | ||||||
| 08/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Central Nervous System | ||||||
| 08/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 44 | 55 | $4,078 | $1,678 |
| 2022 | 2 | 31 | 52 | $6,305 | $2,803 |
| 2021 | 4 | 75 | 109 | $13,275 | $6,283 |
| 2020 | 8 | 211 | 308 | $21,417 | $6,507 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 25 | $3,750 | $1,496 | 39.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 16 | $160.00 | $134.40 | 84.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 14 | $168.00 | $47.74 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 39 | $5,850 | $2,699 | 46.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 13 | $455.00 | $104.34 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 49 | $7,350 | $3,663 | 49.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 14 | $3,850 | $1,482 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 19 | $1,805 | $1,057 | 58.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 20 | 27 | $270.00 | $81.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 70 | $10,500 | $3,704 | 35.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 50 | $4,250 | $2,167 | 51.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 17 | 23 | $805.00 | $170.76 | 21.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 43 | 53 | $530.00 | $157.92 | 29.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 18 | 18 | $900.00 | $148.55 | 16.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 13 | 15 | $900.00 | $96.42 | 10.7% |
| 81002 | Urinalysis, manual test | Office | 2020 | 11 | 11 | $132.00 | $37.93 | 28.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2020 | 14 | 68 | $3,400 | $24.11 | 0.7% |
About Grace Llewellyn, FNP
Grace Llewellyn, FNP is a Family healthcare provider based in Liberty, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2019. The National Provider Identifier (NPI) number assigned to this provider is 1972068674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Grace Llewellyn, FNP has received a total of $3,585 in payments from pharmaceutical and medical device companies, with $1,217 received in 2024. These payments were reported across 227 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($3,585).
As a Medicare-enrolled provider, Llewellyn has provided services to 361 Medicare beneficiaries, totaling 524 services with total Medicare billing of $17,271. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Liberty, MO
- Active Since 02/06/2019
- Last Updated 02/06/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1972068674
Products in Payments
- UBRELVY (Drug) $244.91
- QULIPTA (Drug) $164.06
- VRAYLAR (Drug) $156.70
- MOUNJARO (Drug) $150.66
- NURTEC ODT (Drug) $136.94
- Otezla (Drug) $136.09
- REXULTI (Drug) $133.63
- GEMTESA (Drug) $118.93
- Ozempic (Drug) $111.74
- BELSOMRA (Drug) $105.09
- ELIQUIS (Drug) $103.53
- Rybelsus (Drug) $94.92
- CAPLYTA (Drug) $85.15
- VYVANSE (Drug) $84.85
- EMGALITY (Drug) $81.43
- FARXIGA (Drug) $76.48
- VOQUEZNA (Drug) $70.36
- JARDIANCE (Drug) $69.14
- YUPELRI (Drug) $67.07
- JATENZO (Drug) $66.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Liberty
Mrs. Taryn Beshore, Fnp-C, FNP-C
Family — Payments: $5,964
Lorenzo Black
Family — Payments: $5,091
Mrs. Holly Robin, Np-C, NP-C
Family — Payments: $4,087
Augusta Hall, Fnp - C, FNP - C
Family — Payments: $3,309
Kathryn Morrow, Np, NP
Family — Payments: $3,107
Stacy Browder, Fnp-Bc, FNP-BC
Family — Payments: $3,091